Can I take vitamin D2 (ergocalciferol) and vitamin K while on apixaban (Eliquis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin D2 and Vitamin K Supplementation with Eliquis (Apixaban)

Yes, you can safely take both vitamin D2 (ergocalciferol) and vitamin K while on Eliquis (apixaban), as neither vitamin interacts with apixaban's anticoagulant mechanism.

Why This Combination Is Safe

Apixaban's Mechanism Does Not Involve Vitamin K

  • Apixaban is a direct Factor Xa inhibitor that works independently of the vitamin K clotting pathway, unlike warfarin which directly antagonizes vitamin K 1, 2
  • The European Heart Rhythm Association explicitly distinguishes NOACs (including apixaban) from vitamin K antagonists, noting that NOACs have "fewer food and drug interactions compared with VKAs" 1
  • Vitamin K supplementation does not reverse or interfere with apixaban's anticoagulant effect, as confirmed in the FDA label which states "vitamin K is not expected to affect the anticoagulant activity of apixaban" 2

No Pharmacokinetic Interaction with Vitamins

  • Apixaban is metabolized primarily by CYP3A4 and P-glycoprotein transporters 3, 4
  • Neither vitamin D2 nor vitamin K affects these metabolic pathways 3
  • Vitamin D2 supplementation has well-established effects on calcium and parathyroid hormone but does not interact with anticoagulation systems 5

Important Distinction: Vitamin K vs. Warfarin

  • If you were taking warfarin (Coumadin) instead of Eliquis, vitamin K supplementation would be problematic because warfarin works by blocking vitamin K's role in clotting factor synthesis 6
  • With apixaban (Eliquis), this concern does not apply—you have complete freedom to take vitamin K-containing foods and supplements 1, 2

Actual Drug Interactions to Avoid with Eliquis

High-Risk Combinations That Increase Bleeding

  • NSAIDs (including celecoxib, ibuprofen, naproxen): Increase GI bleeding risk by more than 10-fold when combined with anticoagulants 7, 2
  • Aspirin: Causes 2- to 5-fold increase in bleeding events, particularly when combined with anticoagulants 7, 2
  • Other anticoagulants or antiplatelet agents: Dramatically increase bleeding risk 2
  • SSRIs/SNRIs: Impair platelet function and increase bleeding risk 2

Medications That Alter Apixaban Levels

  • Strong CYP3A4 and P-glycoprotein inhibitors (e.g., ritonavir in Paxlovid, ketoconazole): Significantly increase apixaban concentrations 8, 3
  • Strong CYP3A4 and P-glycoprotein inducers (e.g., rifampin, carbamazepine): Decrease apixaban levels and reduce efficacy 3, 4

Practical Recommendations

  • Continue your vitamin D2 and vitamin K supplements without dose adjustment while on Eliquis 1, 2
  • Standard vitamin D2 dosing of 200,000 IU per day for deficiency treatment is safe and does not require modification for apixaban use 9
  • Monitor for signs of bleeding (unusual bruising, prolonged bleeding, blood in urine or stool) as you would with any anticoagulant, but this is not increased by vitamin supplementation 2
  • Avoid adding NSAIDs or aspirin to your regimen, as these create genuine bleeding risks with apixaban 7, 2

Common Pitfall to Avoid

  • Do not confuse apixaban (Eliquis) with warfarin (Coumadin)—the dietary and supplement restrictions that apply to warfarin patients do not apply to you 1, 2
  • The FDA label explicitly states that protamine sulfate and vitamin K "are not expected to affect the anticoagulant activity of apixaban," confirming no interaction exists 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-drug interactions of non-vitamin K oral anticoagulants.

Expert opinion on drug metabolism & toxicology, 2016

Guideline

Cardiovascular and Gastrointestinal Risks of Celecoxib

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Eliquis Dosing with Paxlovid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Study of the Safe Dosage of Ergocalciferol.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.